Consistent with our previous findings, BBR’s beneficial effects are linked with the downregulation of microRNA34a and long noncoding RNA H19, which are two important players in promoting NASH progression and liver fibrosis. This evidence concerns the gene H19 and metabolic dysfunction-associated steatohepatitis.